Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)

6.71
Delayed Data
As of 3:59pm ET
 +0.16 / +2.44%
Today’s Change
3.11
Today|||52-Week Range
9.93
+66.50%
Year-to-Date
No recent news for Tetraphase Pharmaceuticals Inc.

Today’s Trading

Previous close6.55
Today’s open6.52
Day’s range6.50 - 6.78
Volume921,326
Average volume (3 months)1,008,143
Market cap$334.4M
Dividend yield--
Data as of 3:59pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)+10.59%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-55.97%
P/E ratioNM
Price/Sales28.75
Price/Book1.73

Competitors

 Today’s
change
Today’s
% change
IOVAIovance Biotherapeut...0.000.00%
CNCEConcert Pharmaceutic...+0.14+1.00%
AVDLAvadel Pharmaceutica...-0.16-1.66%
TLGTTeligent Inc0.000.00%
Data as of 3:59pm ET, 09/25/2017

Financials

Next reporting dateNovember 3, 2017
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$5.1M
Annual profit (last year)-$77.5M
Net profit margin-1,505.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Guy MacDonald
Principal Financial &
Accounting Officer
Christopher Watt
Corporate headquarters
Watertown, Massachusetts

Forecasts